Skip to content

Depression: all studies

Page 51 of 1,034: studies 501 to 510 of 10,336, newest first. Back to the depression overview

Research

Examining the effects of psilocybin-assisted psychotherapy on anhedonia in treatment-resistant depression

Journal of Affective Disorders February 12, 2026 Erica Kaczmarek, Nelson Rodriguez, Noah Chisamore et al.

Anhedonia, a core symptom of depression, is often resistant to conventional treatments and significantly impacts quality of life. This secondary analysis aimed to evaluate the effects of psilocybin-assisted psychotherapy (PAP) on anhedonia severity in individuals with treatment-resistant depression (TRD). Participants (n = 30) with TRD and a primary diagnosis of Major Depressive Disorder or...

Low-income group psilocybin assisted therapy for depression: An Oregon feasibility study

Journal of Psychedelic Studies February 12, 2026 Matthew Hicks, Olivia Hicks, Ryan Bradley et al. 2 citations

Abstract Background and aims Despite growing popularity and increasing legal access, psychedelic therapy remains financially inaccessible to many. This study was designed to test the feasibility of conducting group psilocybin therapy in low-income adults with depression in Oregon's regulated psilocybin program. Methods An open label, uncontrolled design was used. After a medical screening...

DOI: 10.1556/2054.2026.00485 (opens in new tab) Psilocybin Adverse effect Depression economics Population +6

MDMA-assisted therapy as a treatment for major depressive disorder: proof of principle study - CORRIGENDUM.

The British Journal of Psychiatry February 10, 2026 Tor-Morten Kvam, Ivar W Goksøyr, Justyna Rog et al.

An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.

Ketamine for depression

February 10, 2026 Jolien K E Veraart

This thesis explores the use of ketamine in people with treatment-resistant depression. It starts by examining the concept of treatment-resistant depression, a term that is widely used but poorly defined. Importantly, this label may negatively influence patients’ expectations and sense of hope. As an alternative, more neutral framing is suggested.Survey data from individuals seeking ketamine...

A moderation examination of the effects of a mindfulness-based intervention on primary school students’ symptoms of inattention, depression, and anxiety

Research Square February 9, 2026 preprint

Abstract The number of mindfulness-based interventions (MBIs) has proliferated in the last decade, as accessible evidence-based practices, to improve children’s mental health in school settings. However, some studies suggest that MBIs do not offer distinct advantages over other mental health promotion interventions. These inconsistent findings may be explained, at least in part, by the lack of...

Effect of subanesthetic dose esketamine on anxiety and depression in patients with breast cancer after surgery: a randomized controlled, double-blind study.

BMC Psychiatry February 9, 2026 Song-Yuan Liu, Rong Huang, Zhuang Liu et al.

BACKGROUND: In recent years, evidence has suggested that subanesthetic doses of esketamine may have beneficial effects on perioperative anxiety and depression. Concurrently, various factors contribute to a high incidence of perioperative depression and anxiety in the breast cancer patient population. This study aimed to explore the impact of preoperative induction and intraoperative maintenance...

The effectiveness of mindfulness-based interventions in reducing anxiety and depression among students: a systematic review and meta-analysis

Clinical Psychologist February 9, 2026 Malak A. Alzahrani, Iman Aly Almohammadi

Objectives With growing interest in mindfulness-based interventions (MBIs) as tools for improving psychological well-being, this systematic review and meta-analysis aimed to evaluate the effectiveness of MBIs in reducing anxiety and depression among students.Method A systematic literature search was conducted across major electronic databases including PubMed, MEDLINE, Web of Science, CENTRAL,...

DOI: 10.1080/13284207.2026.2621341 (opens in new tab) Anxiety Depression economics Psychological intervention Mental health +3

Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression: A Qualitative Exploratory Study

Brain Sciences February 7, 2026 Miriam Olivola, Tiziano Prodi, Giada Versaci et al. 2 citations

Background/Objectives: Esketamine-related dissociation is a transient, pharmacologically induced altered state that differs from the trait-like pathological dissociation typically observed in trauma-related conditions. While most studies have quantified these effects using the Clinician-Administered Dissociative States Scale (CADSS), patients' subjective phenomenology and meaning-making remain...

DOI: 10.3390/brainsci16020196 (opens in new tab) Anxiety Dissociative experiences scale Dissociation chemistry Distress +15

Factors for predicting response to electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) and ketamine in patients with treatment-resistant depression: a systematic review.

International Journal of Psychiatry in Clinical Practice February 7, 2026 Daniel Pustay, Vishal Patel, Krista Ulisse et al.

Treatment-resistant depression (TRD) remains a complex challenge, often requiring interventions beyond standard medications. This review explores factors that may predict positive response to electroconvulsive therapy (ECT), repetitive transcranial magnetic stimulation (rTMS) and ketamine-based treatments to help guide clinical decision-making. A systematic review was conducted following PRISMA...

Effectiveness of ketamine-assisted psychotherapy as a treatment for treatment-resistant depression: a systematic review.

Psychopharmacology February 7, 2026 Rebecca J Simpson, Mario F Juruena 1 citation

Major Depressive Disorder (MDD) is a common and debilitating condition. Current treatments fail to provide adequate relief in roughly one-third of individuals, resulting in treatment-resistant depression (TRD). Ketamine has emerged as a promising intervention for TRD, offering rapid and sustained antidepressant effects. However, benefits often require maintenance dosing, and long-term outcomes...

DOI: 10.1007/s00213-026-07003-0 (opens in new tab) Full text (opens in new tab) Ketamine Combine treatment Psychotherapy Treatment resistant depression